These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Alipour-Khezri E; Skurnik M; Zarrini G Viruses; 2024 Jun; 16(7):. PubMed ID: 39066214 [TBL] [Abstract][Full Text] [Related]
3. Challenges and Promises for Planning Future Clinical Research Into Bacteriophage Therapy Against Rossitto M; Fiscarelli EV; Rosati P Front Microbiol; 2018; 9():775. PubMed ID: 29780361 [TBL] [Abstract][Full Text] [Related]
4. Temperate Bacteriophages from Chronic Pseudomonas aeruginosa Lung Infections Show Disease-Specific Changes in Host Range and Modulate Antimicrobial Susceptibility. Tariq MA; Everest FLC; Cowley LA; Wright R; Holt GS; Ingram H; Duignan LAM; Nelson A; Lanyon CV; Perry A; Perry JD; Bourke S; Brockhurst MA; Bridge SH; De Soyza A; Smith DL mSystems; 2019 Jun; 4(4):. PubMed ID: 31164451 [TBL] [Abstract][Full Text] [Related]
5. Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells. Alemayehu D; Casey PG; McAuliffe O; Guinane CM; Martin JG; Shanahan F; Coffey A; Ross RP; Hill C mBio; 2012; 3(2):e00029-12. PubMed ID: 22396480 [TBL] [Abstract][Full Text] [Related]
6. Design of a Broad-Range Bacteriophage Cocktail That Reduces Pseudomonas aeruginosa Biofilms and Treats Acute Infections in Two Animal Models. Forti F; Roach DR; Cafora M; Pasini ME; Horner DS; Fiscarelli EV; Rossitto M; Cariani L; Briani F; Debarbieux L; Ghisotti D Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555626 [TBL] [Abstract][Full Text] [Related]
7. Current knowledge in the use of bacteriophages to combat infections caused by Pseudomonas aeruginosa in cystic fibrosis. Martínez-Gallardo MJ; Villicaña C; Yocupicio-Monroy M; Alcaraz-Estrada SL; León-Félix J Folia Microbiol (Praha); 2023 Feb; 68(1):1-16. PubMed ID: 35931928 [TBL] [Abstract][Full Text] [Related]
8. Preclinical Development of a Bacteriophage Cocktail for Treating Multidrug Resistant Camens S; Liu S; Hon K; Bouras GS; Psaltis AJ; Wormald PJ; Vreugde S Microorganisms; 2021 Sep; 9(9):. PubMed ID: 34576896 [TBL] [Abstract][Full Text] [Related]
9. A synthetic biology approach to assemble and reboot clinically relevant Ipoutcha T; Racharaks R; Huttelmaier S; Wilson CJ; Ozer EA; Hartmann EM Microbiol Spectr; 2024 Mar; 12(3):e0289723. PubMed ID: 38294230 [TBL] [Abstract][Full Text] [Related]
10. Modular Approach to Select Bacteriophages Targeting Krylov V; Shaburova O; Pleteneva E; Bourkaltseva M; Krylov S; Kaplan A; Chesnokova E; Kulakov L; Magill D; Polygach O Front Microbiol; 2016; 7():1631. PubMed ID: 27790211 [TBL] [Abstract][Full Text] [Related]
12. Tradeoffs Between Evolved Phage Resistance and Antibiotic Susceptibility in a Highly Drug-Resistant Cystic Fibrosis-Derived Wilburn K; Matrishin CB; Choudhury A; Larsen R; Wildschutte H Phage (New Rochelle); 2024 Jun; 5(2):45-52. PubMed ID: 39119204 [TBL] [Abstract][Full Text] [Related]
13. Phage Therapy: An Alternative Approach to Combating Multidrug-Resistant Bacterial Infections in Cystic Fibrosis. Cocorullo M; Stelitano G; Chiarelli LR Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125890 [TBL] [Abstract][Full Text] [Related]
14. In Vitro Newly Isolated Environmental Phage Activity against Biofilms Preformed by Fiscarelli EV; Rossitto M; Rosati P; Essa N; Crocetta V; Di Giulio A; Lupetti V; Di Bonaventura G; Pompilio A Microorganisms; 2021 Feb; 9(3):. PubMed ID: 33668889 [TBL] [Abstract][Full Text] [Related]
15. Phage Therapy Is Effective in a Mouse Model of Bacterial Equine Keratitis. Furusawa T; Iwano H; Hiyashimizu Y; Matsubara K; Higuchi H; Nagahata H; Niwa H; Katayama Y; Kinoshita Y; Hagiwara K; Iwasaki T; Tanji Y; Yokota H; Tamura Y Appl Environ Microbiol; 2016 Sep; 82(17):5332-9. PubMed ID: 27342558 [TBL] [Abstract][Full Text] [Related]
16. Characterization of Pseudomonas lytic phages and their application as a cocktail with antibiotics in controlling Pseudomonas aeruginosa. Ong SP; Azam AH; Sasahara T; Miyanaga K; Tanji Y J Biosci Bioeng; 2020 Jun; 129(6):693-699. PubMed ID: 32107153 [TBL] [Abstract][Full Text] [Related]
17. Directed in Vitro Evolution of Therapeutic Bacteriophages: The Appelmans Protocol. Burrowes BH; Molineux IJ; Fralick JA Viruses; 2019 Mar; 11(3):. PubMed ID: 30862096 [TBL] [Abstract][Full Text] [Related]
18. Susceptibility of Pseudomonas aeruginosa veterinary isolates to Pbunavirus PB1-like phages. Fujiki J; Furusawa T; Munby M; Kawaguchi C; Matsuda Y; Shiokura Y; Nakamura K; Nakamura T; Sasaki M; Usui M; Iwasaki T; Gondaira S; Higuchi H; Sawa H; Tamura Y; Iwano H Microbiol Immunol; 2020 Nov; 64(11):778-782. PubMed ID: 32918505 [TBL] [Abstract][Full Text] [Related]